Case series: indoor-photosensitivity caused by fluorescent lamps in patients treated with vemurafenib for metastatic melanoma

BACKGROUND: Vemurafenib, a selective inhibitor of genetically activated BRAF, is registered for unresectable stage III and stage IV melanomas harboring a BRAF mutation. Photosensitivity related to exposure to sunlight is a common side-effect. We here present three cases of indoor-photosensitivity du...

Descripción completa

Detalles Bibliográficos
Autores principales: Boudewijns, Steve, Gerritsen, Winald R, Koornstra, Rutger H T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301932/
https://www.ncbi.nlm.nih.gov/pubmed/25515496
http://dx.doi.org/10.1186/1471-2407-14-967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301932/
https://www.ncbi.nlm.nih.gov/pubmed/25515496
http://dx.doi.org/10.1186/1471-2407-14-967

Ejemplares similares